Published in Gene Therapy Weekly, June 19th, 1995
The Phase I/II clinical trial will include 20 patients and is being led by Guido Tricot, M.D., Ph.D. and Bart Barlogie, M.D., Ph.D at the Arkansas Cancer Research Center in Little Rock, Arkansas, the world's largest bone-marrow transplant facility for multiple myeloma.
These trials will evaluate SyStemix' highly pure and essentially disease-free hematopoietic stem cell (HSC) transplants, used to support the repopulation of patient's bone marrow and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.